Skip to content

Advance Care Planning in elderly care

Costs and effects of Advance Care Planning in elderly care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23024
Enrollment
196
Registered
2014-01-22
Start date
2014-02-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Care Planning, Respecting Choices, Elderly care, Vroegtijdige Zorgplanning, Ouderen

Interventions

Control groups will be offered usual care. Individuals in the intervention group will be offered formal ACP using the Respecting Choices Model in addition to their usual care. This programme, develop

Sponsors

Erasmus Medical Center Rotterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - > 75 years of age; - Mentally competent, as measured by a Mini–Mental State Examination (MMSE score > 16 and subsequently by judgement of caregiver; - Fluent in Dutch; - Living in a care home or at home receiving home care; - Being frail, as measured by the Tilburg Frailty Index (TFI score of 5 or more) Study participants who leave the care home during follow-up remain included in the study. If study participants pass away during follow-up, the interview will be held with a relative as a proxy for the participant’s perspective

Exclusion criteria

Exclusion criteria: An individual who does not meet the described inclusion criteria will be excluded from participation in this study.

Design outcomes

Primary

MeasureTime frame
Primary effect outcome measure: - Patient activation (PAM-13)

Secondary

MeasureTime frame
- Quality of life (SF-12) - Satisfaction with health care (PSQ-18-SF6) - Health care costs (for the calculation of the health care costs we will distinguish intramural and extramural medical costs) - Use of burdensome medical interventions: hospitalisations, use of ventilation, resuscitation, chemotherapy, feeding tube, operations, antibiotics - Appointment of surrogate decision-maker and documentation of care wishes in advance directives

Contacts

Public ContactI.J. Korfage

Department of Public Health Erasmus MC PO box 2040

i.korfage@erasmusmc.nl+31 (0) 10 7043056

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)